Gene · 6495
Papers2,008
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 2,008
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Effects of Thymidine Phosphorylase and Sine Oculis Homeobox Homologue 1 on the Prognosis and Immune Microenvironment of Gastric Cancer. | Curr Med Sci | 2025 | 40522568 | PubTator, text mining | PubMed |
| Tension-induced enhancement of SIX1 expression during preplacodal ectoderm differentiation from human induced pluripotent stem cells. | Int J Dev Biol | 2025 | 40521683 | PubTator, text mining | PubMed |
| Transcriptomic signatures of rare variant impacts across sex and the X chromosome. | HGG Adv | 2025 | 40452186 | PubTator, text mining | PubMed |
| Single cell transcription revealing key transcription factors in embryonic kidney development. | Mol Cell Biochem | 2025 | 40392427 | PubTator, text mining | PubMed |
| Association of Rare Variants in Kidney Developmental Genes With Chronic Kidney Disease and Blood Pressure: A UK Biobank Study. | WMJ | 2025 | 40262004 | PubTator, text mining | PubMed |
| SIX1 enhances aerobic glycolysis and progression in cervical cancer through ENO1. | Hum Cell | 2025 | 40234326 | PubTator, text mining | PubMed |
| The people behind the papers - Ramya Ranganathan and Andrea Streit. | Development | 2025 | 40213948 | PubTator, text mining | PubMed |
| Kisspeptin 10 Inhibited the Proliferation, Migration, and Stemness of Esophageal Cancer Cells via Regulating the SIX1/Wnt/β-Catetin Signaling. | J Biochem Mol Toxicol | 2025 | 40192612 | PubTator, text mining | PubMed |
| The role of homeobox gene Six1 in cancer progression and its potential as a therapeutic target: A review. | Int J Biol Macromol | 2025 | 40164243 | PubTator, text mining | PubMed |
LncRNA Growth Arrest Specific 5 Promotes Glucose Metabolism Reprogramming Via the IGF2BP1/SIX1 Axis and Inhibits Ferroptosis of Endothelial Progenitor Cells Via the miR-23a-3p/SLC7A11 Axis in Coronary Heart Disease. | Anatol J Cardiol | 2025 | 40062373 | PubTator, text mining | PubMed |
| Inducible, virus-free direct lineage reprogramming enhances scalable generation of human inner ear hair cell-like cells. | bioRxiv | 2025 | 40060658 | PubTator, text mining | PubMed |
| H3K18 lactylation-mediated SIX1 upregulation contributes to silica-induced epithelial-mesenchymal transition in airway epithelial cells. | Toxicology | 2025 | 40049282 | PubTator, text mining | PubMed |
| Coding Genes Helped the Origination and Diversification of Intragenic MicroRNAs. | Mol Biol Evol | 2025 | 39932914 | PubTator, text mining | PubMed |
| Modeling and designing enhancers by introducing and harnessing transcription factor binding units. | Nat Commun | 2025 | 39922842 | PubTator, text mining | PubMed |
| A Novel EYA1 Splicing Mutation in a Chinese Family With Branchio-Oto Syndrome: A Functional Analysis and Reproductive Intervention. | Clin Exp Otorhinolaryngol | 2025 | 39895277 | PubTator, text mining | PubMed |
| Sine oculis homeobox homolog family function in gastrointestinal cancer: Progression and comprehensive analysis. | World J Clin Oncol | 2025 | 39867730 | PubTator, text mining | PubMed |
| Manzamine A: A promising marine-derived cancer therapeutic for multi-targeted interactions with E2F8, SIX1, AR, GSK-3β, and V-ATPase - A systematic review. | Eur J Pharmacol | 2025 | 39863145 | PubTator, text mining | PubMed |
| Whole exome sequencing in 18 Brazilian families with vertical transmission of non-syndromic oral clefts. | J Craniomaxillofac Surg | 2025 | 39855980 | PubTator, text mining | PubMed |
| Correction to "SIX1 Is Upregulated in Gastric Cancer and Regulates Proliferation and Invasion by Targeting the ERK Pathway and Promoting Epithelial-Mesenchymal Transition". | Cell Biochem Funct | 2025 | 39817567 | PubTator, text mining | PubMed |
| The Ku70-SIX1-GPT2 axis regulates alpha-ketoglutarate metabolism to drive progression of prostate cancer. | Oncogene | 2025 | 39488663 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6495/papers?page=4